sees fy adjusted earnings per share $5.09 to $5.19.
sees fy adjusted net income $2.415 billion to $2.470 billion.
sees fy revenue $8.325 billion to $8.475 billion.
qtrly revenue rose 9 percent to $2.2 billion.
qtrly livestock business declined 6% as a result of generic competition for draxxin unfavorable market conditions in u.s.
qtrly u.s. international sales grew 17% versus prior year.